Luis J. Cruz - Concepedia

Author

Luis J. Cruz

Leiden University Medical Center ORCID

Also Known As

Joseph L Hagan, L. J. Cruz, L.J. Cruz, Luis Cruz, Luis J Cruz, Luis J. Cruz, Luis Javier Cruz, Luis J. Cruz

191

Publications

Citations

H-Index

125

Concepts

All Affiliations

Leiden University Medical Center Percuros (Netherlands)Universitat de Barcelona Radboud University Nijmegen Radboud University Medical Center

About

Luis J. Cruz is an author at Leiden University Medical Center specializing in medicine, immunology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	42	2.6K
2	Engineering	18	21	1.5K
3	Natural Sciences	10	10	308
4	Health Sciences	4	4	126
5	Allergy	2	2	39

Luis J. Cruz

104

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro Luis J. Cruz, Paul J. Tacken, Remco Fokkink, Journal of Controlled Release NanoparticlesNanomedicineHuman Dendritic CellsEngineeringImmunology	2010	277
ChemMatrix, a Poly(ethylene glycol)-Based Support for the Solid-Phase Synthesis of Complex Peptides Fayna García‐Martin, Martina Quintanar‐Audelo, Yésica García‐Ramos, Journal of Combinatorial Chemistry	2006	274
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses Rodney Alexander Rosalia, Luis J. Cruz, Suzanne van Duikeren, Biomaterials VaccinationNanomedicineCross-protectionTumor ImmunologyImmunology	2014	265
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells Gerty Schreibelt, Lieke J.J. Klinkenberg, Luis J. Cruz, Blood	2012	241
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study Luis J. Cruz, Rodney Alexander Rosalia, Jan Willem Kleinovink, Journal of Controlled Release NanomedicineImmunologyTherapeutic VaccineT Cell ImmunityTumor Targeting	2014	223
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation Rodney Alexander Rosalia, Esther D. Quakkelaar, Anke Redeker, European Journal of Immunology	2013	204
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells Luis J. Cruz, Paul J. Tacken, Remco Fokkink, Biomaterials NanoparticlesNanomedicineCross-protectionVaccinationHuman Dendritic Cells	2011	194
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity Paul J. Tacken, Ingrid S. Zeelenberg, Luis J. Cruz, Blood	2011	170
Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets Jurjen Tel, Gerty Schreibelt, Simone P. Sittig, Blood	2012	167
Near Infrared Light Sensitive Ultraviolet–Blue Nanophotoswitch for Imaging-Guided “Off–On” Therapy Jing Zuo, Langping Tu, Qiqing Li, ACS Nano	2018	142

Page 1